GRMN vs NXPI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Garmin exhibits strong fundamental health with a Piotroski F-Score of 7/9 and an exceptionally clean balance sheet (Debt/Equity of 0.02). While the stock is trading significantly above its defensive Graham Number ($94.88), it aligns closely with its growth-based intrinsic value of $253.41. However, the bullish fundamental profile is countered by a bearish technical trend (10/100) and significant insider selling by the CEO and CFO. The high PEG ratio of 3.37 suggests the market has already priced in much of the current growth, leaving little margin of safety for new investors.
NXP Semiconductors trades at $197.10, down 10.3% over the past year amid sector-wide semiconductor volatility, yet exhibits strong fundamental resilience and superior profitability relative to peers. Despite near-term revenue contraction (-2.4% YoY), the company maintains best-in-class margins—gross margin of 55.4%, operating margin of 28.24%, and ROE of 20.87%—signaling pricing power and operational efficiency. Forward P/E of 15.08 appears compelling versus sector average P/E of 138.37 and an analyst target price of $258.43, implying 31% upside. Bullish sentiment is reinforced by consistent earnings beats over the last five years and a sustainable 2.06% dividend yield with a 50% payout ratio, though recent insider selling introduces mild caution.
Compare Another Pair
Related Comparisons
GRMN vs NXPI: Head-to-Head Comparison
This page compares Garmin Ltd. (GRMN) and NXP Semiconductors N.V. (NXPI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.